CUSIP 78397T202COM NEWSABSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
48 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 11.42M | $42.71M | 0 | Held |
| 2 | Commodore Capital LP | 4.40M | $16.46M | 0 | Held |
| 3 | Ra Capital Management, L.P. | 4.40M | $16.46M | 0 | Held |
| 4 | Woodline Partners LP | 2.85M | $10.66M |
| 0 |
| Held |
| 5 | Spruce Street Capital LP | 2.20M | $8.22M | +2.20M | New Position |
| 6 | Sessa Capital Im, L.P. | 2.20M | $8.22M | 0 | Held |
| 7 | Blackstone Inc. | 2.14M | $8.02M | +2.14M | New |
| 8 | Vanguard Group Inc | 1.85M | $6.91M | +1.48M | Added |
| 9 | Perceptive Advisors LLC | 803.2K | $3.00M | +803.2K | New |
| 10 | Propel Bio Management, LLC | 652.9K | $2.44M | +652.9K | New |
See every fund holding Sab Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders